<code id='8713EB5714'></code><style id='8713EB5714'></style>
    • <acronym id='8713EB5714'></acronym>
      <center id='8713EB5714'><center id='8713EB5714'><tfoot id='8713EB5714'></tfoot></center><abbr id='8713EB5714'><dir id='8713EB5714'><tfoot id='8713EB5714'></tfoot><noframes id='8713EB5714'>

    • <optgroup id='8713EB5714'><strike id='8713EB5714'><sup id='8713EB5714'></sup></strike><code id='8713EB5714'></code></optgroup>
        1. <b id='8713EB5714'><label id='8713EB5714'><select id='8713EB5714'><dt id='8713EB5714'><span id='8713EB5714'></span></dt></select></label></b><u id='8713EB5714'></u>
          <i id='8713EB5714'><strike id='8713EB5714'><tt id='8713EB5714'><pre id='8713EB5714'></pre></tt></strike></i>

          Home / explore / focus

          focus


          focus

          author:comprehensive    Page View:381
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In